0000000000340705

AUTHOR

A. Vincent

showing 3 related works from this author

Influence de la présence des gènes Rht1 et Rht2 (gènes de réduction de hauteur) sur la composition lipidique de plantules étiolées de blé

1980

National audience

[SDV] Life Sciences [q-bio][SDV]Life Sciences [q-bio]ComputingMilieux_MISCELLANEOUS
researchProduct

On-Line Measurement of Gaseous Iodine Species During a PWR Severe Accident

2015

International audience; Iodine is a highly radio-toxic element, due to its affinity to the thyroid, and represents the major part of the radioactivity released during a nuclear accident. In the context of nuclear safety and radio-protection, we are interested in identifying the iodine gaseous species which are released, in the nuclear power plants, under molecular (I$_2$) and organic (CH$_3$I) forms. Therefore, we are working on providing a spectroscopic database for both species. While the infrared spectrum of the ν6 band of methyl iodide was previously studied, only 4000 lines were assigned. We present the rovibrational analysis of a high quality experimental spectrum, of this band, recor…

[PHYS.NUCL] Physics [physics]/Nuclear Theory [nucl-th]Fission productsRadionuclide[PHYS.NUCL]Physics [physics]/Nuclear Theory [nucl-th]business.industry[PHYS.NEXP] Physics [physics]/Nuclear Experiment [nucl-ex]Nuclear engineeringchemistry.chemical_elementInternational Nuclear Event ScaleNuclear power[PHYS.NEXP]Physics [physics]/Nuclear Experiment [nucl-ex]Iodinecomplex mixtures7. Clean energyAerosolXenonchemistryCaesiumEnvironmental sciencebusiness
researchProduct

Minimal manifestation status and prednisone withdrawal in the MGTX trial

2020

ObjectiveTo examine whether sustained minimal manifestation status (MMS) with complete withdrawal of prednisone is better achieved in thymectomized patients with myasthenia gravis (MG).MethodsThis study is a post hoc analysis of data from a randomized trial of thymectomy in MG (Thymectomy Trial in Non-Thymomatous Myasthenia Gravis Patients Receiving Prednisone Therapy [MGTX]). MGTX was a multicenter, randomized, rater-blinded 3-year trial that was followed by a voluntary 2-year extension for patients with acetylcholine receptor (AChR) antibody–positive MG without thymoma. Patients were randomized 1:1 to thymectomy plus prednisone vs prednisone alone. Participants were age 18–65 years at enr…

Malemedicine.medical_treatmentAzathioprinelaw.invention0302 clinical medicineRandomized controlled trialPrednisonelawMedicineSingle-Blind Method030212 general & internal medicineYoung adultMiddle AgedThymectomyCombined Modality TherapySubstance Withdrawal Syndrome3. Good healthSettore MED/26 - NEUROLOGIA6.1 PharmaceuticalsAnesthesiaadolescent; adult; animals; combined modality therapy; female; humans; immunosuppressive agents; male; middle aged; myasthenia gravis; prednisone; rats; single-blind method; substance withdrawal syndrome; thymoma; thymus neoplasms; young adult; thymectomyCognitive SciencesFemaleImmunosuppressive Agentsmedicine.drugAdultThymomaAdolescentThymomaClinical Trials and Supportive ActivitiesClinical SciencesMGTX study groupAutoimmune DiseaseArticleYoung Adult03 medical and health sciencesRare DiseasesClinical ResearchMyasthenia GravisPost-hoc analysisAnimalsHumansNeurology & Neurosurgerybusiness.industryNeurosciencesEvaluation of treatments and therapeutic interventionsThymus Neoplasmsmedicine.diseaseMyasthenia gravisRatsThymectomyPrednisoneNeurology (clinical)business030217 neurology & neurosurgeryNeurology
researchProduct